Clinical Trial Update: Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia [Phase 4]

View source ↗

Summary

A Phase 4 trial of suvorexant (Belsomra) for bipolar depression with insomnia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Insomnia

Drugs mentioned

• Belsomra (suvorexant)
• Suvorexant (suvorexant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder, Insomnia | Phase 4 | Status: WITHDRAWN